Page 6 - Mankind Pharma

Sensex extends rally to 4th day, ends 123 pts higher; ITC, IT stocks shine

CLOSING BELL ON MAY 30, 2023: The NSE Nifty 50 gained 35 points at 18,634; while the Bank Nifty hit a fresh all-time high at 44,499.

More IPOs need to deliver listing pop to revive retail interest: Analysts

Analysts say retail investors' enthusiasm fizzled out post the muted listing of a majority of public offers in CY22

Mankind Pharma shares bounce back 6% as co clarifies on I-T raid

From a low of Rs 1,356 apiece, the stock vaulted 6 per cent to hit an intra-day high of Rs 1,439

Stocks to Watch on May 12: Adani Total, RIL, TaMo, ONGC, Vedanta, Mankind

Stocks to watch today: Mankind Pharma has confirmed that the Income Tax Department conducted a search at some of the premises/ plants related to the Company and some of its subsidiaries

Income Tax officials search Mankind Pharma's New Delhi office: Report

India's Income Tax Department is conducting searches at Mankind Pharma Ltd's office in New Delhi, a government source told Reuters on Thursday, days after the condom maker's successful public listing

Mankind Pharma jumps 32% on stock market debut due to strong demand

The stellar listing day performance comes even as retail investors gave the Rs 4,326-crore IPO - the largest in more than a year-a miss

Mankind Pharma Ltd surges 23% in Mumbai debut after a $529 mn IPO

Mankind's deal marks the return of mid-to-large-sized debuts in India

Sensex, Nifty end flat after choppy day; Indiabulls RE sinks 20%, Zomato 6%

CLOSING BELL: Among sectors, the Nifty PSU Bank index fell nearly 3 per cent, followed by the Nifty Realty index (close to 1 per cent)

Mankind Pharma lists at 20% premium; should you buy, sell, or hold?

Shares of Mankind listed at Rs 1,300, a 20 per cent premium over its issue price of Rs 1,080 on the National Stock Exchange (NSE) and the BSE

Kansai Nerolac, Canara Bank, Mankind Pharma among top stocks to watch today

Stock to Watch on Tuesday, May 9: Canara Bank's net profit rose 90.6 per cent year-on-year (YoY) at Rs 3,175 crore in Q4FY23

Mankind Pharma to make market debut on Tuesday following a successful IPO

The IPO had seen strong demand from institutional investors even as the retail quota had remained undersubscribed

Sensex leaps 710 pts after a day's hiatus; TaMo, IndusInd rise 5%, PSBs dip

CLOSING BELL: Among sectors, the Nifty Private Bank, Realty, and Auto indices gained around 1.7 per cent each

Mankind Pharma's Rs 4,326-crore IPO garners bids worth Rs 50,000 crore

The Rs 4,326-cr offering garnering bids worth nearly Rs 50,000 cr

Mankind Pharma's initial public offering subscribed 87% on day 2 of issue

Mankind Pharma on Monday allotted shares worth Rs 1,298 crore to 77 anchor investors including 16 domestic mutual funds that participated through 41 schemes

Mankind Pharma's Rs 4,326-crore IPO: Issue subscribed 14% on Day 1

The company's IPO closed on Thursday

Mankind Pharma IPO subscribed 8% so far on Day 1; GMP down 30% in 10 days

The Rs 4,326-crore public issue's price band is set in the range of Rs 1,026-1,080 per share. The issue will close on Thursday, April 27

Mankind Pharma IPO opens today: Check GMP, price band, other details here

Mankind Pharma IPO listing date: The IPO is likely to list on NSE and BSE on May 8

Mankind Pharma raises Rs 1,298 cr from anchor investors ahead of IPO

Canada Pension Plan Investment Board (CPPIB), the Government of Singapore, SBI Multi Cap Fund, and Fidelity Investment Trust were some investors who were allotted shares under the anchor quota

Is Mankind Pharma IPO worth a subscription? Here's what brokerages suggest

In the grey markets, shares of Mankind Pharma enjoyed a premium of Rs 90, which translated to a likely listing price of Rs 1,170 per share on the upper price band

Street signs: Defence stocks may rise, Mankind Pharma IPO, and more

After having recorded seven straight months of outflows, equity savings schemes are expected to witness a change of fortune in the months ahead